0001214659-21-003204.txt : 20210316
0001214659-21-003204.hdr.sgml : 20210316
20210316202018
ACCESSION NUMBER: 0001214659-21-003204
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210312
FILED AS OF DATE: 20210316
DATE AS OF CHANGE: 20210316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cochran John
CENTRAL INDEX KEY: 0001406773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 21748017
MAIL ADDRESS:
STREET 1: 201 MAIN STREET, SUITE 1900
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001398733
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208623253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-941-1900
MAIL ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: MonoSol Rx, Inc.
DATE OF NAME CHANGE: 20070507
4
1
marketforms-51914.xml
PRIMARY DOCUMENT
X0306
4
2021-03-12
0001398733
Aquestive Therapeutics, Inc.
AQST
0001406773
Cochran John
C/O AQUESTIVE THERAPEUTICS, INC.
30 TECHNOLOGY DRIVE
WARREN
NJ
07059
true
false
false
false
Common Stock
2021-03-12
4
J
false
23038
0
A
98123
D
Common Stock
2021-03-12
4
J
false
8228
0
A
106351
D
Common Stock
2021-03-12
4
J
false
11544
0
A
117895
D
Common Stock
2021-03-12
4
J
false
19091
0
A
136986
D
Pro rata distributions for no consideration of shares of common stock of the Issuer by the following entities, respectively (collectively, the "Distributing Entities"): MonoLine Rx, L.P., MonoLine Rx III, L.P., MonoSol Rx Genpar, L.P., and MRX Partners, LLC. The Reporting Person under this Form 4 possesses no voting or investment control over the securities held by the Distributing Entities.
/s/ Robert Arnold, as Attorney-In-Fact
2021-03-16